ROP Score 3 vs NeoFast Calc
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
ROP Score 3
This medical app predicts severe retinopathy of prematurity (ROP) using specific parameters. It aims to reduce unnecessary screenings in low-risk infants by calculating a score at 2 or 6 weeks of life. Key inputs include birth weight, gestational age, and weight gain.
- Predicts severe ROP
- Calculates score at 2 or 6 weeks
- Reduces unnecessary screenings
- Uses birth weight and gestational age
- Considers weight gain and medical history
Read full descriptionHide full description
ROPScore predicts severe ROP assuming a specific cut off level that needs to be validated for each population. The score is calculated once per child at 2 or 6 weeks of life. The aim is to decrease the number of screened children and/or reduce the frequency of examinations in low risk infants. This process requires the following parameters: BW, GA, weight gain proportional to BW measured at the given week, the presence or absence of blood transfusion and oxygen in mechanical ventilation up to the analyzed week.
NeoFast Calc
This medical reference tool simplifies daily tasks for healthcare professionals caring for newborns and children. It provides evidence-based prescribing assistance, drug interaction information, and extensive data on over 990 drug presentations.
- Neonatal and pediatric prescribing assistance
- Drug interaction and antagonist information
- Adverse reaction and brand name details
- Dose adjustment for renal/hepatic impairment
- Extensive drug presentation database
- Bibliographic references
Read full descriptionHide full description
An intuitive tool that aims to make the daily routine of all healthcare professionals who care for children and newborns easier. This application is based on several sources from national and international literature to assist in prescribing according to the dose stipulated by the neonatologist. In addition, it has a range of additional information on drug interactions, antagonists (in cases of poisoning or overdose), adverse reactions, international brands names, stability and conservation, dose adjustment in renal and hepatic impairment, general guidelines, etc. It also has more than 990 drug presentations and more than 160 worldwide bibliographic references. Therefore, it is a tool that ensures safety and agility on medical duty. Privacy Policy (EULA): https://neofastapp.com/privacy-terms/ Terms of use: https://neofastapp.com/privacy-terms/
Screenshots
Verdict
The clearest difference is in-app purchases: ROP Score 3 at none against NeoFast Calc's 2. ROP Score 3 also leads on review sentiment (100% vs 80%) and iOS requirement (9.0 vs 15.6). On price, ads and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. NeoFast Calc sells 2 in-app purchases, starting at $5.99 per month. ROP Score 3 asks for nothing beyond the download.
| Parameter | ROP Score 3 | NeoFast Calc |
|---|---|---|
| Price | Free | Free |
| Positive reviews | 100.0% of reviews — better | 80.0% of reviews |
| Update frequency | — | Every 2 weeks |
| Ads | No | No |
| In-app purchases | No — better | Yes |
| Monetization | Free — better | Freemium |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 9.0 — better | 15.6 |
| Further details — not scored | ||
| Size | 3 MB | 195 MB |
| Age rating | 4+ | 17+ |
| Developer | German Parisi | Ponto Direto Tech Ltda |
Customer experience
ROP Score 3
NeoFast Calc
In-app purchases
ROP Score 3
No in-app purchases
NeoFast Calc
- NeoFast® - Monthly Plan1 Month trial$5.991 Month
- NeoFast® - Yearly Plan1 Month trial$59.991 Year








